You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial
|
---|---|
Published in |
Lancet Infectious Diseases, October 2023
|
DOI | 10.1016/s1473-3099(23)00350-x |
Pubmed ID | |
Authors |
Jing-Xin Li, Li-Hua Hou, Jin-Bo Gou, Zun-Dong Yin, Shi-Po Wu, Fu-Zhen Wang, Zhe Zhang, Zhi-Hang Peng, Tao Zhu, Hong-Bing Shen, Wei Chen, Feng-Cai Zhu, Si-Yue Jia, Rong Tang, Hong-Xing Pan, Li Zhang, Jia-Wei Xu, Ji-Hai Tang, Qing Wang, Qing Xu, Yan Zheng, Tao Huang, Tao Li, Shu-Jun Liu, Cang-Ning Wang |
X Demographics
The data shown below were collected from the profiles of 3,963 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 665 | 17% |
Canada | 254 | 6% |
United Kingdom | 135 | 3% |
Australia | 90 | 2% |
Mexico | 90 | 2% |
France | 83 | 2% |
Japan | 52 | 1% |
Germany | 47 | 1% |
Spain | 40 | 1% |
Other | 278 | 7% |
Unknown | 2229 | 56% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3487 | 88% |
Scientists | 223 | 6% |
Practitioners (doctors, other healthcare professionals) | 178 | 4% |
Science communicators (journalists, bloggers, editors) | 75 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 18 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 22% |
Student > Bachelor | 2 | 11% |
Unspecified | 1 | 6% |
Lecturer > Senior Lecturer | 1 | 6% |
Other | 1 | 6% |
Other | 2 | 11% |
Unknown | 7 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 3 | 17% |
Medicine and Dentistry | 2 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Nursing and Health Professions | 1 | 6% |
Other | 3 | 17% |
Unknown | 7 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1624. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2023.
All research outputs
#6,519
of 24,891,087 outputs
Outputs from Lancet Infectious Diseases
#50
of 5,913 outputs
Outputs of similar age
#161
of 333,947 outputs
Outputs of similar age from Lancet Infectious Diseases
#2
of 158 outputs
Altmetric has tracked 24,891,087 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,913 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 91.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,947 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.